Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
12.92
-0.08 (-0.62%)
At close: Jul 11, 2025, 4:00 PM
12.50
-0.42 (-3.25%)
After-hours: Jul 11, 2025, 5:23 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $25.41 million as of July 11, 2025. Its market cap has increased by 238.43% in one year.
Market Cap
25.41M
Enterprise Value
18.07M
1-Year Change
238.43%
Ranking
Category
Stock Price
$12.92
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $25.41M, a decrease of -56.32%. That is a compound annual growth rate of -28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 25.41M | -1.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |